BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wong-Chong J, Bernadach M, Ginzac A, Veyssière H, Durando X. Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report. World J Clin Cases 2021; 9(5): 1139-1147 [PMID: 33644178 DOI: 10.12998/wjcc.v9.i5.1139]
URL: https://www.wjgnet.com/2307-8960/full/v9/i5/1139.htm
Number Citing Articles
1
Yi-Fan Jiang, Jian Wu, Di-Yu Chen. A rare case of thymic carcinoma metastasize to liverHepatobiliary & Pancreatic Diseases International 2023;  doi: 10.1016/j.hbpd.2023.12.003
2
Carboplatin/paclitaxelReactions Weekly 2021; 1847(1): 123 doi: 10.1007/s40278-021-92680-z
3
Yoichi Nishii, Kazuki Furuhashi, Kentaro Ito, Tadashi Sakaguchi, Yuta Suzuki, Kentaro Fujiwara, Taro Yasuma, Tetsu Kobayashi, Corina N. D’Alessandro-Gabazza, Esteban C. Gabazza, Osamu Taguchi, Osamu Hataji. Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case ReportPharmaceuticals 2022; 15(7): 889 doi: 10.3390/ph15070889